Clinical Trial Update: Lenalidomide, Vorinostat and Dexamethasone in Relapsed Patients With Peripheral T-Cell Non-Hodgkin's Lymphoma (PTCL) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating the combination of lenalidomide, vorinostat, and dexamethasone in relapsed Peripheral T-Cell Non-Hodgkin's Lymphoma was terminated. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Non-hodgkin Lymphoma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)
• Vorinostat (vorinostat)

Snippet

Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie | Conditions: Peripheral T-Cell Non-Hodgkin's Lymphoma | Phase 1, Phase 2 | Status: TERMINATED